Symptom Assessment During Childhood Cancer Treatment

Abstract

Get full access to this article

View all access options for this article.

References

Baggott

Dodd

Kennedy

Marina

Matthay

K. K.

Cooper

B. A.

Miaskowski

(2010). Changes in children’s reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy. Journal of Pediatric Oncology Nursing, 27, 307-315. doi:10.1177/1043454210377619

Buckner

T. W.

Wang

DeWalt

D. A.

Jacobs

Reeve

B. B.

Hinds

P. S.

(2014). Patterns of symptoms and functional impairments in children with cancer. Pediatric Blood & Cancer, 61, 1282-1288. doi:10.1002/pbc.25029

D’Angio

G. J.

(1975). Pediatric cancer in perspective: cure is not enough. Cancer, 35(3 Suppl.), 866-870.

Hockenberry

M. J.

Hooke

M. C.

Gregurich

McCarthy

Sambuco

Krull

(2010). Symptom clusters in children and adolescents receiving cisplatin, doxorubicin, or ifosfamide. Oncology Nursing Forum, 37, E16-E27. doi:10.1188/10.ONF.E16-E27

Landier

Leonard

Ruccione

K. S.

(2013). Children’s Oncology Group’s 2013 blueprint for research: nursing discipline. Pediatric Blood & Cancer, 60, 1031-1036. doi:10.1002/pbc.24415

Siegel

R. L.

Miller

K. D.

Jemal

(2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. doi:10.3322/caac.21551